CDX2's positive nature in the prostate specimens, as well as the original bowel specimens from this case, strongly correlate with a diagnosis of metastatic spread from the original cecal adenocarcinoma to the prostate. This evidence concerns the gene CDX2 and cecum adenocarcinoma.